Alivio de la apnea del sueño en una pastilla: Los datos de la Fase 3 del medicamento de Apnimed preparan el escenario para la presentación ante la FDA.
Standard treatment for breathing issues caused by obstructive sleep apnea typically involves using a medical device, such as a continuous positive airway pressure (CPAP) machine. However, many individuals find wearing the CPAP mask uncomfortable. Apnimed, a startup company, has developed an experimental drug, AD109, that could offer a more convenient alternative. Results from a pivotal … Leer más
